INTERNATIONAL PATENT: TAKEDA PHARMACEUTICAL COMPANY LIMITED FILES APPLICATION FOR "HYPOIMMUNOGENIC MODIFIED GAMMA DELTA T CELLS"

GENEVA, April 6 -- TAKEDA PHARMACEUTICAL COMPANY LIMITED (1-1, Doshomachi 4-chome, Chuo-ku, Osaka-shiOsaka 541-0045) filed a patent application (PCT/IB2025/059684) for "HYPOIMMUNOGENIC MODIFIED GAMMA DELTA T CELLS" on Sep 25, 2025. With publication no. WO/2026/069206, the details related to the patent application was published on Apr 02, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SHI, Xi (c/o TAKEDA DEVELOPMENT CENTER AMERICAS, INC.500 Kendall StreetCambridge, Massachusetts 02142), NG, Mei Rosa (c/o TAKEDA DEVELOPMENT CENTER AMERICAS, INC.500 Kendall StreetCambridge, Massachusetts 02142...